GB1565333A - Method for the preparation of specific immune serum and use therof - Google Patents

Method for the preparation of specific immune serum and use therof Download PDF

Info

Publication number
GB1565333A
GB1565333A GB13320/78A GB1332078A GB1565333A GB 1565333 A GB1565333 A GB 1565333A GB 13320/78 A GB13320/78 A GB 13320/78A GB 1332078 A GB1332078 A GB 1332078A GB 1565333 A GB1565333 A GB 1565333A
Authority
GB
United Kingdom
Prior art keywords
serum
iap
immune serum
specific immune
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB13320/78A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KAYAKU ANTIBIOTIC RESEARCH CO
Kayaku Kosei Bushitsu Kenkyujo KK
Saikin Kagaku Kenkyujo KK
Original Assignee
KAYAKU ANTIBIOTIC RESEARCH CO
Kayaku Kosei Bushitsu Kenkyujo KK
Saikin Kagaku Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KAYAKU ANTIBIOTIC RESEARCH CO, Kayaku Kosei Bushitsu Kenkyujo KK, Saikin Kagaku Kenkyujo KK filed Critical KAYAKU ANTIBIOTIC RESEARCH CO
Publication of GB1565333A publication Critical patent/GB1565333A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB13320/78A 1977-06-16 1978-04-05 Method for the preparation of specific immune serum and use therof Expired GB1565333A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7134977A JPS548714A (en) 1977-06-16 1977-06-16 Production of specific antiserum

Publications (1)

Publication Number Publication Date
GB1565333A true GB1565333A (en) 1980-04-16

Family

ID=13457921

Family Applications (1)

Application Number Title Priority Date Filing Date
GB13320/78A Expired GB1565333A (en) 1977-06-16 1978-04-05 Method for the preparation of specific immune serum and use therof

Country Status (7)

Country Link
US (1) US4269765A (enExample)
JP (1) JPS548714A (enExample)
CA (1) CA1093964A (enExample)
CH (1) CH640639A5 (enExample)
DE (1) DE2814121C3 (enExample)
FR (1) FR2394805A1 (enExample)
GB (1) GB1565333A (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56132563A (en) * 1980-03-21 1981-10-16 Terumo Corp Reagent for testing biological material and use thereof
JPS56142459A (en) * 1980-04-08 1981-11-06 Terumo Corp Living substance inspecting method and container therefore
US4447545A (en) * 1980-11-03 1984-05-08 New England Deaconess Hospital Bladder cancer detection
US4656025A (en) * 1985-04-19 1987-04-07 Emmanuel Deutsch Quantitative screening assay of tumor globulin from gastric juice
JPS62135297U (enExample) * 1986-02-20 1987-08-26
JPS62161494U (enExample) * 1986-04-01 1987-10-14
JPS6344592U (enExample) * 1986-09-08 1988-03-25

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819822A (en) * 1969-12-18 1974-06-25 Kowa Co Diagnostic agent for detection of primary hepatoma
SE388284B (sv) * 1969-12-18 1976-09-27 Kowa Co Gelmedium for diagnos av primert hepatom medelst immundiffusion eller elektrofores
GB1291134A (en) * 1970-01-21 1972-09-27 Anvar A process for the production of mammal cell anti-sera
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine
GB1388719A (en) * 1971-09-02 1975-03-26 Hadassah Medical Relief Ass In Pure t-globulin and its anti-serum
FR2222084B1 (enExample) * 1973-03-22 1976-05-14 Fontaine Michel
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm

Also Published As

Publication number Publication date
DE2814121A1 (de) 1978-12-21
DE2814121C3 (de) 1980-06-26
FR2394805A1 (fr) 1979-01-12
FR2394805B1 (enExample) 1980-08-08
DE2814121B2 (de) 1979-10-04
CH640639A5 (de) 1984-01-13
JPS548714A (en) 1979-01-23
US4269765A (en) 1981-05-26
JPS6118699B2 (enExample) 1986-05-14
CA1093964A (en) 1981-01-20

Similar Documents

Publication Publication Date Title
Ablin et al. Tissue-and species-specific antigens of normal human prostatic tissue
Bienenstock et al. Secretory γA in normal urine
Linke et al. Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.
US4340581A (en) Process for the immunological determination of basal membrane material and new basal membrane suitable therefor
Nopparatana et al. Purification of Gnathostoma spinigerum specific antigen and immunodiagnosis of human gnathostomiasis
Butler Physicochemical and immunochemical studies on bovine IgA and glycoprotein-a
Lee et al. Decreased serum group‐specific component protein levels and complexes with actin in fulminant hepatic necrosis
Shimano et al. Isolation, characterization and clinical evaluation of a pancreas cancer‐associated antigen
Hochwald et al. Trace Proteins in Biological Fluids. IV. Physicochemical Properties and Sites of Formation of γ-Trace and β-Trace Proteins.
Suzuki et al. Enzyme activation by antibody: I. Fractionation of immune sera in search for an enzyme activating antibody
US4269765A (en) Immune serum for diagnosis of cancer and preparation thereof
Trump Goldfish immunoglobulins and antibodies to bovine serum albumin
Shiloah et al. Phospholipase isoenzymes from Naja naja venom—I. Purification and partial characterization
US4746731A (en) Isolated tissue protein PP18
JPS5959621A (ja) 新規蛋白質およびその濃縮および取得法
Eveleigh Heterogeneity of carcinoembryonic antigen
Hamashige et al. Immunologic and biologic study of human chorionic gonadotropin
Korngold Antigenic specificity of γ2-myeloma globulins
Archer et al. Eosinophil granule lysis in vitro induced by soluble antigen antibody complexes
WO1981001849A1 (en) Purified human prostate antigen
Loor et al. Purification and characterization of a human pancreas-specific antigen
Hamashige et al. Human chorionic gonadotropin: A hormone complex
Childs et al. Cross idiotypic specificity among heavy chains of macroglobulins with blood group I and i specificities
Litman et al. The evolution of the immune response: IX. Immunoglobulins of the bowfin: purification and characterization
Keir et al. Nitrocellulose immunofixation following agarose electrophoresis in the study of immunoglobulin G subgroups in unconcentrated cerebrospinal fluid

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19960405